• Akbasak A, Oldfield EH, Saris SC (1991) Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. J Neurosurg. 75, 922929.
  • Barker FG 2nd, Chang SM, Larson DA, Sneed PK, Wara WM, Wilson CB, Prados MD (2001) Age and radiation response in glioblastoma multiforme. Neurosurgery 49, 12881297. Discussion 1297–1288.
  • CBTRUS (2005) Statistical report: Primary brain tumors in the United States, 1998–2002. Published by the Central Brain Tumor Registry of the United States. Hinsdale, IL. Website:
  • Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl Cancer Inst. 85, 704710.
  • Glass R, Synowitz M, Kronenberg G, Walzlein J-H, Markovic DS, Wang L-P, Gast D, Kiwit J, Kempermann G, Kettenmann H (2005) Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J. Neurosci. 25, 26372646.
  • Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448452.
  • Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 64, 479489.
  • Rosenblum ML, Gerosa M, Dougherty DV, Reese C, Barger GR, Davis RL, Levin VA, Wilson CB (1982) Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet 1, 885887.
  • Stiles CD, Rowitch DH (2008) Glioma stem cells: a midterm exam. Neuron 58, 832846.
  • Wheeler CJ, Black KL, Liu G, Ying H, Yu JS, Zhang W, Lee PK (2003) Thymic CD8+ cell production strongly influences tumor antigen recognition and age-dependent glioma mortality. J. Immunol. 171, 49274933.